The effect of hydrazine synthesis derivative of naproxen on histopathology of the liver and liver enzymes in Three spot Gourami Fish(Trichogaster trichopterus)

Document Type : scientific research article

Authors

1 Corresponding Author, Associate Prof., Dept. of Basic Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Tehran Medical Science, Islamic Azad University, Tehran, Iran

2 Full Professor Iranian Fisheries Science Research Institute, Agricultural Research, Education and Extension Organization, Tehran, Iran

3 Full Professor, Dept. of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

4 Doctorate in Pharmacy, Dept. of Basic Sciences, Faculty of Pharmaceutical Science, Tehran Medical Science, Islamic Azad University, Tehran, Iran

Abstract

Hydrazones are an important class of bioactive drugs that have attracted much attention .One of the domains in this category of compounds is the synthesis of new hydrazone derivatives from NSAIDs, which are supposed to be more effective than the previous synthesized derivatives in terms of effect strength and severity of the complications. Many compounds of different chemical derivatives are designed and synthesized to treat various diseases, among which hydrazones are included, and their anti-cancer effects have been reported so far .The aim of this study was to investigate the hepatotoxicity profile of 4-chlorobenzolidin-hydrazine-naproxen derivatives and compare it with the main drug, naproxen. 120 fish specimens of Trichogaster trichopterus with average weight of 2.4±1 gr in 8 treatments were divided into control groups, control1 (intact), control2 (DMSO) and treatment groups receiving 10, 20, 30 mg/kg of naproxen and 10, 20, 30 mg/kg of hydrazine naproxen derivatives. These concentrations were selected according to previous works and related articles. After anesthetizing the fishes, liver tissue and liver enzymes were studied in treatment groups and the groups receiving the drug compared with control groups. The statistical results of the level of liver enzymes between control groups and treatments showed a significant difference (P<0/05). Histopathological examination of the liver tissue of the treatments indicated that the liver tissue had undergone a major change in the high doses of both drugs. The results showed that naproxen and hydrazine naproxen derivatives affect liver tissue and liver enzymes by increasing doses and increased sinusoidal spacing, and adipose vacuoles in liver.

Keywords

Main Subjects

References

1.Zimmerman, H. J. (1999). Drugs used to treat rheumatic and musculospastic disease. The NSAIDS. . In, Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. edition. Lippinco Williams & wilkins, Philadelphia. 517-554.
2.Ali, M. R., Marella, A., Alam, M. T., Naz, R., Akhter, M., Shaquiquzzaman, M., & Hooda, J. (2012). Review of biological activities of hydrazones. Indones. J. Pharm. 193-202.
3.Takatsuki, A., & Yamaguchi, I. (2001). Fish reproduction as an indicator of endocrine disruption by chemical compounds. Riken Review. 43-44.
4.Fosbol, E. L., Gislason, G. H., Jacobsen, S., Folke, F., Hansen, M. L., Schramm, T. K., & Traerup, J. (2009). Risk of myocardial infarction and death associated with the use of nonsteroidal anti‐inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study. Clin. Pharmacol. Ther. 85 (2), 190-197.
5.Azizian, H., Mousavi, Z., Faraji, H., Tajik, M., Bagherzadeh, K., Bayat, P., & Almasirad, A. (2016). Arylhydrazone derivatives of naproxen as new analgesic and anti-inflammatory agents: Design, synthesis and molecular docking studies. J. Mol. Graph . 67, 127-136.
6.Nasri, S., & Ebrahimi, S. (2006). [Medical effect of Vitex agnus-castus. J. Babol Univ. Med. Sci. 7, 49-53.  
7.Rodríguez, L. A. G., Williams, R., Derby, L. E., Dean, A. D., & Jick, H. (1994). Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors. Arch. Intern. Med. 154 (3), 311-316.
8.Manoukian, A. V., & Carson, J. L. (1996). Nonsteroidal anti-inflammatory drug-induced hepatic disorders. Drug Safety. 15 (1), 64-71.
9.Aithal, P. G., & Day, C. P. (1999). The natural history of histologically proved drug induced liver disease. Gut. 44 (5), 731-735.
10.Sgro, C., Clinard, F., Ouazir, K., Chanay, H., Allard, C., Guilleminet, C., & Hillon, P. (2002). Incidence of drug-induced hepatic injuries: French population-based study. Hepatology. 36 (2), 451-455.
11.Limdi, J. K, & Hyde, G. M. 2003. Evaluation of abnormal liver function tests. Postgrad Med. J. 79 (932), 307-12.
12.Giannini, E. G., Testa, R., & Savarino, V. (2005). Liver enzyme alternation: a guide for clinicians. Cmaj. 172 (3), 367-79.
13.Lin, S. H., Wang, C. Y., Ho, J. C., & Wu, W. M. (2010). Naproxen-induced pseudo lymphoma syndrome: a case report. Dermatol Sin. 28 (1), 27-31.
14.Carrascosa, M. F., Lucena, M. I., Andrade, R. J., Caviedes, J. R. S., Lavín, A. C., Mones, J. C., & Serrano, V. B. (2009). Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection. Clin Ther. 31 (5), 1014-1019.
15.Razzaq, I. H. A. (2015). Study of the Toxic effect of new Cadmium (II) complex [CdL2]. 1/2H2O on GPT and ALP activity in some organs of female mice comparable with antitumor drug Cyclophosphamide (CP). Baghdad Sci. J. 12 (1), 140-147.
16.Zuo, A. R., Yu, Y. Y., Shu, Q. L., Zheng, L. X., Wang, X. M., Peng, S. H., & Cao, S. W. (2014). Hepatoprotective effects and antioxidant, anti-tyrosinase activities of phloretin and phloretin isonicotinyl hydrazone. J. Chin. Med. Assoc. 77 (6), 290-301.
17.Georgieva, N., Gadjeva, V., & Tolekova, A. (2004). New isonicotinoylhydrazones with SSA protect against oxidative-hepatic injury of isoniazid. Tanzan. J. Sci. 2, 37-43.
Journal of Utilization and Cultivation of Aquatics
Volume 12, Issue 3
October 2023
Pages 159-170

Files

Share

How to cite

Statistics